Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of medical conditions. Over the past decade, there has been considerable excitement about using MSCs to treat neurodegenerative diseases, which are diseases that are typically fatal and without other robust therapies. In this review, we discuss the proposed MSC mechanisms of action in neurodegenerative diseases, which include growth factor secretion, exosome secretion, and attenuation of neuroinflammation. We then provide a summary of preclinical and early clinical work on MSC therapies in amyotrophic lateral sclerosis, multiple system atrophy, Parkinson disease, and Alzheimer disease. Continued rigorous and controlled studies of MSC therapies will be critical in order to establish efficacy and protect patients from possible untoward effects.

Original languageEnglish (US)
Pages (from-to)892-905
Number of pages14
JournalMayo Clinic proceedings
Volume94
Issue number5
DOIs
StatePublished - May 2019

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases'. Together they form a unique fingerprint.

  • Cite this